will improve staging and follow-up of therapy in patients with neuroendocrine tumors. Somatostatin analogs (e.g., octreotide, lanreotide) will continue to be main therapies for functioning ...

The treatment and clinical outcome of patients with neuroendocrine tumors ... techniques are needed for accurate staging and treatment of the tumor. Current markers include plasma levels of ...

AMT-676 is under clinical development by Multitude therapeutics and currently in Phase I for Neuroendocrine Tumors.

The FDA will review an application for Cabometyx as a potential treatment for pancreatic neuroendocrine tumors after findings from a phase 3 trial. Understanding how I fit in matters to me but ...

I will love you forever.” Furthermore, Emilia also spoke to TMZ and claimed that Paul was diagnosed with stage 4 neuroendocrine pancreatic cancer in April, this year, and since then, he has been ...

According to GlobalData, Phase II drugs for Neuroendocrine Tumors have a 28% phase transition success rate (PTSR ... GlobalData’s Likelihood of Approval analytics tool dynamically assesses and ...

WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has unveiled significant preclinical results for its ...

Irrfan Khan died of a neuroendocrine tumour (NET) — the 'forgotten cancer' — earlier today, April 29. The cancer is rare and often misdiagnosed as other common ailments like IBS, asthma or ...

Award follows extensive pre-clinical, single agent activity data generated by Prof. Colleen Nelson's lab at QUT in 'Aggressive Variant' prostate ca ...

Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for ...